Skip to main content
logo
Nanjing Vazyme Biotech Co., Ltd (SHA:688105)
China flag China · Delayed Price · Currency is CNY
22.00
+0.33 (1.52%)
Jan 23, 2026, 3:00 PM CST

Revenue by Product

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Biological Reagents
1.11B
Log In
Log In
Log In
Log In
Upgrade
Biological Reagents Growth
17.43%
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Reagents
157.13M
Log In
Log In
Log In
Log In
Upgrade
Diagnostic Reagents Growth
-36.72%
Log In
Log In
Log In
Log In
Upgrade
Instruments and Equipment
44.89M
Log In
Log In
Log In
Log In
Upgrade
Instruments and Equipment Growth
116.15%
Log In
Log In
Log In
Log In
Upgrade
Technical Services
41.44M
Log In
Log In
Log In
Log In
Upgrade
Technical Services Growth
-30.46%
Log In
Log In
Log In
Log In
Upgrade
Consumables and Other Materials
23.95M
Log In
Log In
Log In
Log In
Upgrade
Consumables and Other Materials Growth
112.72%
Log In
Log In
Log In
Log In
Upgrade
Other Business
2.31M
Log In
Log In
Log In
Log In
Upgrade
Other Business Growth
-3.98%
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Quantitative Polymerase Chain Reaction Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Quantitative Polymerase Chain Reaction Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Colloidal Gold Immunochromatographic Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Polymerase Chain Reaction Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Polymerase Chain Reaction Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Gene Sequencing Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Gene Sequencing Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Reverse Transcription Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Reverse Transcription Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Quantum Dot Immunofluorescence Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Quantum Dot Immunofluorescence Reagent Growth
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Molecular Cloning Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Molecular Cloning Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Point-of-care Testing Diagnostic Reagent - Fluorescence Polymerase Chain Reaction Nucleic Acid Detection Reagent
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Extraction and Purification Series
-
Log In
Log In
Log In
Log In
Upgrade
Biological Reagent - Extraction and Purification Series Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
China
1.27B
Log In
Log In
Log In
Log In
Upgrade
China Growth
26.86%
Log In
Log In
Log In
Log In
Upgrade
Overseas
101.22M
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
194.99%
Log In
Log In
Log In
Log In
Upgrade